Interleukin‐6 (IL‐6) is a typical inflammatory cytokine, and its level is known to be increased in patients with cancer.8 IL‐6 not only induces differentiation of B‐lymphocytes into plasma cells to produce immunoglobulins, but also decreases albumin production in the liver.9 This evidence concerns the gene ALB and cancer.